Delivery Order SPE2DB24D2205-SPE2DB25FDYLT

Award Date 2/18/25
Potential Completion Date 2/19/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,018.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXCOM G7 sensors, a medical device used for diabetes management. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $1,058.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of DEXCOM G7 SENSORS, a medical device used for diabetes management. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of December 3, 2024. This contract award is a child of a larger Indefinite Delivery Contract...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,724.24 firm fixed-price delivery order is for the procurement of DEXCOM G7 SENSORS, a medical device used for diabetes management. The award has an ultimate completion date of October 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,684.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXCOM G7 SENSORS, a medical device used in the management of diabetes. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of February 11, 2025. This award is associated with a larger Indefinite Delivery...
This federal contract award, valued at $1,086.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dexcom G7 sensors, a medical device for diabetes management. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award, valued at $10,490.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXCOM G7 SENSORS, a critical medical device for diabetes management. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $5,144.46, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the provision of DEXCOM G7 SENSORS, a medical device used for diabetes management. This is a delivery order issued under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a comprehensive...
This federal contract award, valued at $2,439.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXCOM G7 SENSORS, a medical device used for diabetes management. This is a firm fixed-price delivery order contract with a period of performance through December 30, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This federal contract award is for the delivery of DEXCOM G7 SENSORS, a medical device for diabetes management, to the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm fixed-price delivery order with a ceiling value of $1,056.98 and a performance period through January 28, 2025. The award is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $1,042.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXCOM G7 SENSORS, a type of medical device, and has an ultimate completion date of February 27, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and is not designated with any set-aside requirements, indicating open competition....
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDYLT
    Delivery Order

This federal contract award, valued at $1,675.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXCOM G7 SENSORS, a medical device used in the management of diabetes.

The award is a delivery order issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and the contract is a firm-fixed-price arrangement with a period of performance through February 2025.

Generated 5/20/25, 2:19 PM